Co-Authors
This is a "connection" page, showing publications co-authored by ASHOK BALASUBRAMANYAM and RAJAGOPAL SEKHAR.
Connection Strength
2.764
-
Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome. Metabolism. 2012 Oct; 61(10):1395-403.
Score: 0.421
-
Treatment of dyslipidemia in HIV-infected patients. Expert Opin Pharmacother. 2010 Aug; 11(11):1845-54.
Score: 0.373
-
HIV-associated lipodystrophy syndrome: an accelerated form of the metabolic syndrome of insulin resistance due to altered fat distribution. Res Initiat Treat Action. 2006; 12(1):5-11.
Score: 0.271
-
Severely dysregulated disposal of postprandial triacylglycerols exacerbates hypertriacylglycerolemia in HIV lipodystrophy syndrome. Am J Clin Nutr. 2005 Jun; 81(6):1405-10.
Score: 0.261
-
Cardiovascular implications of HIV-associated dyslipidemic lipodystrophy. Curr Atheroscler Rep. 2004 May; 6(3):173-9.
Score: 0.242
-
Metabolic basis of HIV-lipodystrophy syndrome. Am J Physiol Endocrinol Metab. 2002 Aug; 283(2):E332-7.
Score: 0.214
-
HIV-1 Vpr induces adipose dysfunction in vivo through reciprocal effects on PPAR/GR co-regulation. Sci Transl Med. 2013 Nov 27; 5(213):213ra164.
Score: 0.117
-
Relationship of ethnicity and CD4 Count with glucose metabolism among HIV patients on Highly-Active Antiretroviral Therapy (HAART). BMC Endocr Disord. 2013 Apr 22; 13:13.
Score: 0.113
-
Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr. 2011 Sep; 94(3):847-53.
Score: 0.100
-
Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial. J Clin Endocrinol Metab. 2011 Jul; 96(7):2236-47.
Score: 0.098
-
Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care. 2011 Jan; 34(1):162-7.
Score: 0.094
-
Effects of rosiglitazone on abnormal lipid kinetics in HIV-associated dyslipidemic lipodystrophy: a stable isotope study. Metabolism. 2011 Jun; 60(6):754-60.
Score: 0.094
-
Dysregulated energy expenditure in HIV-infected patients: a mechanistic review. Clin Infect Dis. 2007 Jun 01; 44(11):1509-17.
Score: 0.074
-
Effects of transgenic expression of HIV-1 Vpr on lipid and energy metabolism in mice. Am J Physiol Endocrinol Metab. 2007 Jan; 292(1):E40-8.
Score: 0.071
-
Heart positive: design of a randomized controlled clinical trial of intensive lifestyle intervention, niacin and fenofibrate for HIV lipodystrophy/dyslipidemia. Contemp Clin Trials. 2006 Dec; 27(6):518-30.
Score: 0.070
-
Physiologic growth hormone replacement improves fasting lipid kinetics in patients with HIV lipodystrophy syndrome. Am J Clin Nutr. 2006 Jul; 84(1):204-11.
Score: 0.070
-
Regulation of body weight by proopiomelanocortin peptides in humans: lessons from the Nelson syndrome. Ann Intern Med. 2005 Aug 02; 143(3):238-9.
Score: 0.066
-
Short- and long-term effects of growth hormone (GH) replacement on protein metabolism in GH-deficient adults. J Clin Endocrinol Metab. 2003 Dec; 88(12):5827-33.
Score: 0.015